#AUA14 - The role of obesity in the incidence of lymphatic spread, disease-free and overall survival: Data from the ARISER clinical trial - Session Highlights

ORLANDO, FL USA (UroToday.com) - The relationship between obesity and high-risk clear cell type RCC is not clear. Karim Chamie and colleagues studied the association of obesity with lymphatic spread and survival in patients from an international phase III clinical trial which tested the efficacy of cG250 antibodies in patients with high risk for recurrence of high-risk clear cell RCC.

auaThe authors reviewed clinical and pathologic records of 864 patients from the phase III clinical trial. They assessed patient BMI in addition to other demographic status. BMI was stratified into widely accepted BMI groups. They then calculated for the association between BMI, severity of disease, and survival in patients with clear cell RCC.

They found that majority of patients were overweight and obese. Interestingly, they found that increasing BMI led to a decrease incidence of lymphatic spread in their cohort of patients. Furthermore, obesity was associated with improved disease-free and overall survival.

The authors concluded that in their cohort of patients, for those who had had nephrectomies for RCC, obesity was beneficial. This is a very interesting finding as previous belief has been that obesity is associated with higher risk of having kidney cancer. The results of the study may indicate that BMI is not a good indicator of kidney cancer. Taking into account the weight loss of patients is necessary to confirm the conclusions from the study, patients in the obese category may not have lost as much weight, a factor that is usually associated with worsening disease.

Presented by Karim Chamie, MD at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

Los Angeles, CA USA

Written by Garen Abedi, MD, University of California (Irvine), and medical writer for UroToday.com

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2020 Annual Meeting / June 27-28 / AUA Live Virtual Program
  • 2020 Annual Meeting / May 29-31 / Virtual Scientific Program
  • 2020 Winter Meeting / February 25-29 / Scottsdale, AZ
  • 2020 Annual Meeting / February 13-15 / San Francisco, CA
  • 2019 Annual Meeting / December 4-6 / Washington, DC
  • 2019 Annual Congress / October 17 - October 20 / Athens, Greece
  • 2019 Annual Meeting / October 3 - October 5 / Aarhus, Denmark
  • 2019 Annual Congress / September 27 - October 1 / Barcelona, Spain
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland
  • 2019 Think Tank / August 8-10 / Washington, DC
  • 2019 Annual Meeting / May 31 - June 6 / Chicago, IL
  • 2019 Annual Meeting / May 3-6 / Chicago, IL